Liraglutide With Metformin Therapy Ameliorates Hepatic Steatosis and Liver Injury in a Mouse Model of Non-alcoholic Steatohepatitis - CHIU, HONG-YI; TSAI, SHIH-CHANG; TSAI, FUU-JEN; LO, YU-HSIANG; CHENG, CHING-CHANG; LIU, TING-YUAN; JHAN, SYUN-RONG; YANG, JAI-SING; CHIU, YU-JEN (In vivo (Athens), 2023)
Keywords: Alanine Transaminase; Animals; Choline - metabolism; Choline - pharmacology; Choline - therapeutic use; Diabetes; Diet; Disease Models, Animal; Enzymes; Fatty liver; FDA approval; Glucagon; Insulin resistance; Laboratory animals; Liraglutide - metabolism; Liraglutide - pharmacology; Liraglutide - therapeutic use; Liver - pathology; Liver cirrhosis; Metabolism; Metformin - pharmacology; Methionine - metabolism; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease - drug therapy; Non-alcoholic Fatty Liver Disease - etiology; Non-alcoholic Fatty Liver Disease - metabolism; Obesity; Variance analysis; Weight control; United States--US; MCD diet; metformin; liver injury; C57BL/6JNarl mouse model; Liraglutide; non-alcoholic steatohepatitis